Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study

被引:0
作者
William B. Young
J. Ivan Lopez
John F. Rothrock
Amelia Orejudos
Aubrey Manack Adams
Richard B. Lipton
Andrew M. Blumenfeld
机构
[1] Jefferson Hospital for Neuroscience,
[2] University of South Alabama College of Medicine,undefined
[3] George Washington School of Medicine,undefined
[4] Allergan plc,undefined
[5] Montefiore Headache Center,undefined
[6] Department of Neurology,undefined
[7] Department of Epidemiology and Population Health,undefined
[8] Albert Einstein College of Medicine,undefined
[9] Headache Center of Southern California,undefined
[10] The Neurology Center,undefined
来源
The Journal of Headache and Pain | 2019年 / 20卷
关键词
COMPEL; Daily headache; Disability; Migraine; OnabotulinumtoxinA; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 174 条
[51]  
Dodick DW(undefined)undefined undefined undefined undefined-undefined
[52]  
Aurora SK(undefined)undefined undefined undefined undefined-undefined
[53]  
Turkel CC(undefined)undefined undefined undefined undefined-undefined
[54]  
DeGryse RE(undefined)undefined undefined undefined undefined-undefined
[55]  
Lipton RB(undefined)undefined undefined undefined undefined-undefined
[56]  
Silberstein SD(undefined)undefined undefined undefined undefined-undefined
[57]  
Brin MF(undefined)undefined undefined undefined undefined-undefined
[58]  
Dodick DW(undefined)undefined undefined undefined undefined-undefined
[59]  
Turkel CC(undefined)undefined undefined undefined undefined-undefined
[60]  
DeGryse RE(undefined)undefined undefined undefined undefined-undefined